Scientists from the NIH’s National Human Genome Research Institute (NHGRI) and Undiagnosed Diseases Program (UDP) have identified a new rare […]
In a recent paper published in Proceedings of the Royal Society, researchers trained ants to become olfactory cancer tumour bio-sensors. […]
Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
Join us for our latest webinar series, Genomics in Drug Discovery ONLINE, to discover how we can harness the latest […]
Join us for our latest 3-part webinar series, Biodata and AI in Drug Discovery, to uncover how experts organise data […]
Erik Ingelsson (Senior Vice President of Genomic Sciences at GlaxoSmithKline) joins us to discuss the importance of genetics in drug […]
Please note the transcript has been edited for brevity and clarity. FLG: Hello, everyone, and welcome to our interview with […]
Join us for Genomics in Drug Discovery ONLINE, a unique 3-part webinar series, where we explore the role of genetics […]
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf
The Mandela Effect refers to a situation in which a large mass of people believes that an event occurred when […]
